Modulators of cystic fibrosis transmembrane conductance regulator protein

wherein R1, m, Z, G1, R2, and R3 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Bogdan, Andrew, Chan, Vincent, Koenig, John R, Shekhar, Shashank, Wang, Xueqing, Malagu, Karine Fabienne, Patel, Sachin V, Searle, Xenia B, Liu, Bo, Yeung, Ming C, Scanio, Marc, Altenbach, Robert J, Grieme, Timothy A, Kym, Philip R
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!